PatentChecker
Demo: Delivery IP risk report for viral-vector programs
A deterministic scorecard that asks the right question before clinic: can this therapy actually get delivered without running into external vector IP, licensing choke points, or manufacturing dependency?
This is a demo artifact. It is not legal advice and not an infringement or freedom-to-operate conclusion.
Blocking readout
Overall
93.45
Critical
Status
High Blocking Risk
Method: weighted_sum_v1
Program
Prime CNS candidate
Prime Medicine
External control
REGENXBIO, RoyaltyBank
2 matched families
Why this scores as blocking
High-overlap delivery claims line up with externally controlled families and likely create a preclinical blocking zone.
Evidence
2 matched documents
3 ownership records
REGENXBIO matched assignees
Confidence
Level: High
Ownership coverage: Present
Score: 0.91
Program metadata
AAV · AAV9
Target tissues: CNS, muscle
Payload capacity: Dual
Immune profile: Moderate
Manufacturing: HEK293
capsid_sequencepackaging_systempayload_strategypromoter_specificitytropism_engineeringvector_genome_design
Scoring components
Capsid overlap
2 matched documents include capsid-sequence claim language
100
Average Overlap Score: 1
Capsid Focused Documents: 2
Claim Ref Count: 3
Matched Document Count: 2
Matched Family Count: 2
Max Overlap Score: 1
Licensing dependency
1 secured parties were found on matched families
100
External Control Party Count: 2
Externally Controlled Family Count: 2
High Overlap External Document Count: 2
Ownership Record Count: 3
Secured Party Count: 1
Sponsor Controlled Family Count: 0
Manufacturing dependency
1 manufacturing-sensitive documents map to externally controlled families
71
Declared Manufacturing Method Count: 1
Externally Controlled Manufacturing Document Count: 1
Manufacturing Document Count: 1
Manufacturing Focus Delivery Systems: 1
Exclusivity zones
2 matched families fall into externally controlled zones
95
Exclusive Party Count: 1
Externally Controlled Family Count: 2
High Overlap Family Count: 2
Matched Family Count: 2
Max External Party Family Coverage: 2
Matched documents
The report ties the program’s declared delivery system to claim-facet signals, then checks whether ownership evidence points to an external blocking zone.
| Publication | Assignees | Claims | IP focus | Max overlap |
|---|---|---|---|---|
US2026000003 fam_aav_ext1 | REGENXBIO | Delivery 1 (1.00), Manufacturing 7 (0.81) | capsid_sequencepackaging_systempayload_strategypromoter_specificitytropism_engineeringvector_genome_design | 1.00 |
US2026000004 fam_aav_ext2 | REGENXBIO | Method 1 (1.00) | capsid_sequencepayload_strategy | 1.00 |
Download and verify
Public sample artifacts
Verify
curl -LO https://omnisgenomics.com/patent-checker/delivery-risk-demo/delivery-risk-report.sample.v0.1.json curl -LO https://omnisgenomics.com/patent-checker/delivery-risk-demo/watchlist.delivery-risk.sample.v0.1.json curl -LO https://omnisgenomics.com/patent-checker/delivery-risk-demo/claim-facets-set.delivery-risk.sample.v0.1.json curl -LO https://omnisgenomics.com/patent-checker/delivery-risk-demo/ownership-set.delivery-risk.sample.v0.1.json curl -LO https://omnisgenomics.com/patent-checker/delivery-risk-demo/delivery-risk-demo.sha256 sha256sum -c delivery-risk-demo.sha256
watchlist_sha256
sha256:2344ac056186be460571a2e64347e07db1ac40bcbc42001e4b39e23b619e8345
claim_facets_set_sha256
sha256:3b0c0f069026295544f431709fbf8bf96623ffdb94931dc92abefa75c4b172e4
ownership_set_sha256
sha256:0b574023f74c8e4cffa1067aa6aaba56b7e9bf3548fec23c1ec11df797cbc69b
Guardrails
- Outputs are informational; not legal advice.
- Delivery risk scores are heuristic and deterministic; they do not establish infringement, validity, or enforceability.
- Matched documents reflect claim-facet signal overlap, not claim construction or doctrine-of-equivalents analysis.
- Ownership-sensitive components understate risk when ownership_set coverage is absent or incomplete.
- Programs without explicit delivery_system metadata should be modeled in watchlist.v0.1.json before using this scorer.
View full delivery-risk-report.sample.v0.1.json
{
"canonicalization": {
"float_decimals": 6,
"scheme_id": "pc-canon-v1"
},
"compiler": {
"name": "patentchecker",
"version": "0.1.52"
},
"confidence": {
"level": "high",
"ownership_coverage": "present",
"score": 0.91
},
"evidence_summary": {
"external_control_parties": [
"REGENXBIO",
"RoyaltyBank"
],
"matched_assignees": [
"REGENXBIO"
],
"matched_document_count": 2,
"matched_family_count": 2,
"ownership_record_count": 3,
"secured_parties": [
"RoyaltyBank"
]
},
"generated_at": "2026-01-05T00:00:00Z",
"inputs": {
"claim_facets_set_sha256": "sha256:3b0c0f069026295544f431709fbf8bf96623ffdb94931dc92abefa75c4b172e4",
"ownership_set_sha256": "sha256:0b574023f74c8e4cffa1067aa6aaba56b7e9bf3548fec23c1ec11df797cbc69b",
"watchlist_sha256": "sha256:2344ac056186be460571a2e64347e07db1ac40bcbc42001e4b39e23b619e8345"
},
"interpretation_guardrails": [
"Outputs are informational; not legal advice.",
"Delivery risk scores are heuristic and deterministic; they do not establish infringement, validity, or enforceability.",
"Matched documents reflect claim-facet signal overlap, not claim construction or doctrine-of-equivalents analysis.",
"Ownership-sensitive components understate risk when ownership_set coverage is absent or incomplete.",
"Programs without explicit delivery_system metadata should be modeled in watchlist.v0.1.json before using this scorer."
],
"matched_documents": [
{
"assignees": [
"REGENXBIO"
],
"claim_refs": [
{
"claim_no": "1",
"claim_type": "delivery",
"delivery_system_id": "ds_aav9_dual",
"matched_ip_focus": [
"capsid_sequence",
"payload_strategy",
"promoter_specificity",
"tropism_engineering",
"vector_genome_design"
],
"matching_signal_keys": [
"delivery:aav",
"viral_vector:capsid_sequence",
"viral_vector:payload_strategy",
"viral_vector:promoter_specificity",
"viral_vector:tropism_engineering",
"viral_vector:vector_genome_design"
],
"overlap_score": 1,
"reasons": [
"Claim includes viral-vector-specific language",
"Claim type is delivery-specific",
"Matched IP focus capsid_sequence",
"Matched IP focus payload_strategy",
"Matched IP focus promoter_specificity",
"Matched IP focus tropism_engineering",
"Matched IP focus vector_genome_design",
"Matched delivery class signal delivery:aav"
]
},
{
"claim_no": "7",
"claim_type": "manufacturing",
"delivery_system_id": "ds_aav9_dual",
"matched_ip_focus": [
"packaging_system"
],
"matching_signal_keys": [
"delivery:aav",
"viral_vector:packaging_system"
],
"overlap_score": 0.81,
"reasons": [
"Claim includes viral-vector-specific language",
"Claim reaches declared manufacturing or packaging path",
"Claim type is manufacturing-specific",
"Matched IP focus packaging_system",
"Matched delivery class signal delivery:aav"
]
}
],
"family_id": "fam_aav_ext1",
"jurisdiction": "US",
"matched_ip_focus": [
"capsid_sequence",
"packaging_system",
"payload_strategy",
"promoter_specificity",
"tropism_engineering",
"vector_genome_design"
],
"matched_signals": [
"delivery:aav",
"viral_vector:capsid_sequence",
"viral_vector:packaging_system",
"viral_vector:payload_strategy",
"viral_vector:promoter_specificity",
"viral_vector:tropism_engineering",
"viral_vector:vector_genome_design"
],
"max_overlap_score": 1,
"publication_number": "US2026000003",
"relevant_delivery_system_ids": [
"ds_aav9_dual"
]
},
{
"assignees": [
"REGENXBIO"
],
"claim_refs": [
{
"claim_no": "1",
"claim_type": "method",
"delivery_system_id": "ds_aav9_dual",
"matched_ip_focus": [
"capsid_sequence",
"payload_strategy"
],
"matching_signal_keys": [
"delivery:aav",
"viral_vector:capsid_sequence",
"viral_vector:immune_evasion",
"viral_vector:payload_strategy"
],
"overlap_score": 1,
"reasons": [
"Claim includes viral-vector-specific language",
"Matched IP focus capsid_sequence",
"Matched IP focus payload_strategy",
"Matched delivery class signal delivery:aav"
]
}
],
"family_id": "fam_aav_ext2",
"jurisdiction": "US",
"matched_ip_focus": [
"capsid_sequence",
"payload_strategy"
],
"matched_signals": [
"delivery:aav",
"viral_vector:capsid_sequence",
"viral_vector:immune_evasion",
"viral_vector:payload_strategy"
],
"max_overlap_score": 1,
"publication_number": "US2026000004",
"relevant_delivery_system_ids": [
"ds_aav9_dual"
]
}
],
"program": {
"delivery_systems": [
{
"capsid_variant": "AAV9",
"delivery_system_id": "ds_aav9_dual",
"domain": "DeliverySystem",
"immune_profile": "moderate",
"ip_focus": [
"capsid_sequence",
"packaging_system",
"payload_strategy",
"promoter_specificity",
"tropism_engineering",
"vector_genome_design"
],
"manufacturing_method": "HEK293",
"payload_capacity": "dual",
"subdomain": "ViralVector",
"target_tissues": [
"CNS",
"muscle"
],
"vector_type": "AAV"
}
],
"name": "Prime CNS candidate",
"program_id": "prog_prime_cns",
"sequence_ids": [
"seq_prime_cns"
],
"sponsor_entities": [
"Prime Medicine"
]
},
"schema_name": "patentchecker.delivery_risk_report",
"schema_version": "0.1",
"score": {
"band": "critical",
"blocking_assessment": {
"reason": "High-overlap delivery claims line up with externally controlled families and likely create a preclinical blocking zone.",
"status": "high_blocking_risk"
},
"component_details": {
"exclusivity_zones": {
"metrics": {
"exclusive_party_count": 1,
"externally_controlled_family_count": 2,
"high_overlap_family_count": 2,
"matched_family_count": 2,
"max_external_party_family_coverage": 2
},
"reasons": [
"2 matched families fall into externally controlled zones",
"At least one external party controls 2 matched families"
],
"score": 95,
"weight": 0.15
},
"licensing_requirements": {
"metrics": {
"external_control_party_count": 2,
"externally_controlled_family_count": 2,
"high_overlap_external_document_count": 2,
"ownership_record_count": 3,
"secured_party_count": 1,
"sponsor_controlled_family_count": 0
},
"reasons": [
"1 secured parties were found on matched families",
"2 matched families are controlled by non-sponsor parties"
],
"score": 100,
"weight": 0.25
},
"manufacturing_dependency": {
"metrics": {
"declared_manufacturing_method_count": 1,
"externally_controlled_manufacturing_document_count": 1,
"manufacturing_document_count": 1,
"manufacturing_focus_delivery_systems": 1
},
"reasons": [
"1 manufacturing-sensitive documents map to externally controlled families",
"1 matched documents include manufacturing or packaging language"
],
"score": 71,
"weight": 0.2
},
"overlap_with_existing_capsid_patents": {
"metrics": {
"average_overlap_score": 1,
"capsid_focused_documents": 2,
"claim_ref_count": 3,
"matched_document_count": 2,
"matched_family_count": 2,
"max_overlap_score": 1
},
"reasons": [
"2 matched documents include capsid-sequence claim language",
"Maximum delivery-claim overlap reached 1"
],
"score": 100,
"weight": 0.4
}
},
"components": {
"exclusivity_zones": 95,
"licensing_requirements": 100,
"manufacturing_dependency": 71,
"overlap_with_existing_capsid_patents": 100
},
"method": "weighted_sum_v1",
"overall": 93.45,
"scale_max": 100,
"scale_min": 0,
"weights": {
"exclusivity_zones": 0.15,
"licensing_requirements": 0.25,
"manufacturing_dependency": 0.2,
"overlap_with_existing_capsid_patents": 0.4
}
},
"watchlist": {
"name": "Delivery Risk Demo Watchlist",
"watchlist_id": "wl_delivery_demo"
}
}